The clinical trial of pharmaceutical company Eli Lilly and Company’s antibody COVID-19 treatment was paused because of some potential safety concerns. Eli Lilly announced trial halt just a day after Johnson & Johnson disclosed the pause o...
With COVID-19 pushing the Kiwi Land into its worst recession in decades, investors remain jittery over the potential impact of this large-scale economic downturn on the equity market. Amidst this mounting uncertainty, it seems imperative for NZ inv...
The ongoing COVID-19 pandemic has affected nearly 33.25 million individuals, including ~1 million deaths, as reported to the WHO as of 5:08 PM CEST on 28 September 2020. Many healthcare companies are engaged in the development of vaccines, treatmen...
While Kiwi Land’s stringent lockdown restrictions enabled it to gain control over the COVID-19 spread, these curbs delivered a crushing blow to the flourishing travel sector. At the time when NZ is pulling out all the stops to reboot its mult...
The COVID-19 vaccine prospects have intensified with Johnson & Johnson (NYSE:JNJ) disclosing the commencement of its Phase 3 clinical trial (ENSEMBLE) as a COVID-19 vaccine candidate. JNJ’s candidate is the fourth candidate which is under...
COVID-19 cases were first detected in Wuhan, China in December last year, however, the disease started picking up the momentum by March, and it is then that the local governments took the initiative of imposing lockdown to contain its further sprea...
The magnitude of COVID-19 disaster was initially underestimated by the policymakers worldwide. However, deep repercussions of the pandemic have ignited debates of its close resemblance with the global financial crisis (GFC) of 2008-2009. At the tim...
The COVID-19 storm that has created havoc in the world, is not showing any signs of abating with the world witnessing an ongoing increase in the number of new cases daily. According to the WHO (World Health Organization), globally, there have been ...
While the Kiwi Land is battling with the second wave of COVID-19 infections and resultant lockdown restrictions, stronger than anticipated performance of the NZ economy has taken the world by surprise. Moreover, some optimistic signs of recovery ar...
What was believed to be the most-promising coronavirus vaccine study from AstraZeneca and the University of Oxford has been paused indefinitely, due to the alleged unexplained illness that one of the participants had developed. Phase III vaccine t...
Get a call to receive stock recommendation services from (www.kalkine.co.nz)
